
Alicia L. Otton
Examiner (ID: 9618)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1699, 4121 |
| Total Applications | 1585 |
| Issued Applications | 975 |
| Pending Applications | 99 |
| Abandoned Applications | 544 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18329176
[patent_doc_number] => 11634404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Selective D
[patent_app_type] => utility
[patent_app_number] => 16/093365
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 24
[patent_no_of_words] => 11193
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093365 | Selective D | Apr 13, 2017 | Issued |
Array
(
[id] => 13805069
[patent_doc_number] => 10179796
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-15
[patent_title] => Pharmaceutical compounds
[patent_app_type] => utility
[patent_app_number] => 15/487980
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5669
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487980
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487980 | Pharmaceutical compounds | Apr 13, 2017 | Issued |
Array
(
[id] => 15008443
[patent_doc_number] => 10450337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Pharmaceutical compounds
[patent_app_type] => utility
[patent_app_number] => 15/487970
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5728
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15487970
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/487970 | Pharmaceutical compounds | Apr 13, 2017 | Issued |
Array
(
[id] => 11993935
[patent_doc_number] => 20170298090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'Modulators of ROR-gamma Receptors, Composition and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/481591
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16891
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481591
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481591 | Modulators of ROR-gamma Receptors, Composition and Use Thereof | Apr 6, 2017 | Abandoned |
Array
(
[id] => 11987746
[patent_doc_number] => 20170291901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => '1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/481083
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15575
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15481083
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/481083 | 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 Inhibitors | Apr 5, 2017 | Abandoned |
Array
(
[id] => 14213627
[patent_doc_number] => 20190119198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => BIODEGRADABLE AMINO-ESTER NANOMATERIALS FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/091062
[patent_app_country] => US
[patent_app_date] => 2017-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091062 | Biodegradable amino-ester nanomaterials for nucleic acid delivery | Apr 5, 2017 | Issued |
Array
(
[id] => 11755966
[patent_doc_number] => 20170202833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'ORAL FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 15/479409
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5160
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15479409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/479409 | ORAL FORMULATION | Apr 4, 2017 | Abandoned |
Array
(
[id] => 15355489
[patent_doc_number] => 10526345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Compounds as GPR119 agonists
[patent_app_type] => utility
[patent_app_number] => 15/478883
[patent_app_country] => US
[patent_app_date] => 2017-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22491
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478883
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478883 | Compounds as GPR119 agonists | Apr 3, 2017 | Issued |
Array
(
[id] => 14371083
[patent_doc_number] => 20190159454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
[patent_app_type] => utility
[patent_app_number] => 16/092059
[patent_app_country] => US
[patent_app_date] => 2017-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092059 | Substituted oxadiazoles for combating phytopathogenic fungi | Mar 30, 2017 | Issued |
Array
(
[id] => 17089683
[patent_doc_number] => 11117860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Phenyl urea derivatives as n-formyl peptide receptor modulators
[patent_app_type] => utility
[patent_app_number] => 16/090068
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16054
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 378
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090068 | Phenyl urea derivatives as n-formyl peptide receptor modulators | Mar 27, 2017 | Issued |
Array
(
[id] => 12509025
[patent_doc_number] => 10000458
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Production method of 1, 2, 4-triazole compound
[patent_app_type] => utility
[patent_app_number] => 15/471670
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10986
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471670
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471670 | Production method of 1, 2, 4-triazole compound | Mar 27, 2017 | Issued |
Array
(
[id] => 14485115
[patent_doc_number] => 10329324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Indoline compounds as granzyme B inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/470596
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 40946
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15470596
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/470596 | Indoline compounds as granzyme B inhibitors | Mar 26, 2017 | Issued |
Array
(
[id] => 18070524
[patent_doc_number] => 11529340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Combination for treating pain
[patent_app_type] => utility
[patent_app_number] => 16/088000
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 38
[patent_no_of_words] => 10631
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088000 | Combination for treating pain | Mar 21, 2017 | Issued |
Array
(
[id] => 16141311
[patent_doc_number] => 10703716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Antibacterial compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/085947
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 13655
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085947 | Antibacterial compounds and methods of use thereof | Mar 19, 2017 | Issued |
Array
(
[id] => 12562848
[patent_doc_number] => 10016519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
[patent_app_type] => utility
[patent_app_number] => 15/463059
[patent_app_country] => US
[patent_app_date] => 2017-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7860
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15463059
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/463059 | 18F-tagged inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | Mar 19, 2017 | Issued |
Array
(
[id] => 17307319
[patent_doc_number] => 11208411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Compositions and methods for treating parasitic diseases
[patent_app_type] => utility
[patent_app_number] => 16/085981
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71422
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085981 | Compositions and methods for treating parasitic diseases | Mar 16, 2017 | Issued |
Array
(
[id] => 16312264
[patent_doc_number] => 20200291002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
[patent_app_type] => utility
[patent_app_number] => 16/083972
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083972 | Benzofuran derivatives for the treatment of hepatitis C | Mar 16, 2017 | Issued |
Array
(
[id] => 11706672
[patent_doc_number] => 20170175171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'METHODS AND KITS FOR BREAKING EMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 15/449192
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12002
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449192 | Methods and kits for breaking emulsions | Mar 2, 2017 | Issued |
Array
(
[id] => 17095347
[patent_doc_number] => 20210283138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => SUBSTITUTED INDOLE MCL-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/081709
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081709 | Substituted indole Mcl-1 inhibitors | Mar 2, 2017 | Issued |
| 15/448398 | VOLTAGE SENSITIVE DYES | Mar 1, 2017 | Abandoned |